APO Research

APO RESEARCH · REPORT

Esketamine Hydrochloride Injection

Selected research

Market Analysis & Forecast

Global Esketamine Hydrochloride Injection Market Analysis and Forecast 2026-2032

Market perspective

The global Esketamine Hydrochloride Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Esketamine Hydrochloride Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Esketamine Hydrochloride Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Esketamine Hydrochloride Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Esketamine Hydrochloride Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Esketamine Hydrochloride Injection include Jiangsu Hengrui Medicine, Pfizer and Laboratoires CDM Lavoisier, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Esketamine Hydrochloride Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Esketamine Hydrochloride Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Esketamine Hydrochloride Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Esketamine Hydrochloride Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Esketamine Hydrochloride Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Esketamine Hydrochloride Injection sales, projected growth trends, production technology, application and end-user industry.

Esketamine Hydrochloride Injection Segment by Company

Jiangsu Hengrui Medicine

Pfizer

Laboratoires CDM Lavoisier

Esketamine Hydrochloride Injection Segment by Type

2ml:50mg

5ml:25mg

Others

Esketamine Hydrochloride Injection Segment by Application

Hospitals and Clinics

Ambulatory Surgery Centers

Esketamine Hydrochloride Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Esketamine Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Esketamine Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Esketamine Hydrochloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Esketamine Hydrochloride Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Esketamine Hydrochloride Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Esketamine Hydrochloride Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Esketamine Hydrochloride Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 2ml:50mg Major Manufacturers Table 3. 5ml:25mg Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Esketamine Hydrochloride Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals and Clinics Major Manufacturers Table 7. Ambulatory Surgery Centers Major Manufacturers Table 8. Esketamine Hydrochloride Injection Industry Trends Table 9. Esketamine Hydrochloride Injection Industry Drivers Table 10. Esketamine Hydrochloride Injection Industry Opportunities and Challenges Table 11. Esketamine Hydrochloride Injection Industry Restraints Table 12. Global Esketamine Hydrochloride Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Esketamine Hydrochloride Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Esketamine Hydrochloride Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Esketamine Hydrochloride Injection Revenue Market Share by Region (2021-2026) Table 16. Global Esketamine Hydrochloride Injection Revenue Market Share by Region (2027-2032) Table 17. Global Esketamine Hydrochloride Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Esketamine Hydrochloride Injection Sales by Region (2021-2026) & (K Units) Table 19. Global Esketamine Hydrochloride Injection Sales by Region (2027-2032) & (K Units) Table 20. Global Esketamine Hydrochloride Injection Sales Market Share by Region (2021-2026) Table 21. Global Esketamine Hydrochloride Injection Sales Market Share by Region (2027-2032) Table 22. Global Esketamine Hydrochloride Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Esketamine Hydrochloride Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Esketamine Hydrochloride Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Esketamine Hydrochloride Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Esketamine Hydrochloride Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Esketamine Hydrochloride Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Esketamine Hydrochloride Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Esketamine Hydrochloride Injection Manufacturers, Product Type & Application Table 30. Global Esketamine Hydrochloride Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Esketamine Hydrochloride Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Esketamine Hydrochloride Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Esketamine Hydrochloride Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Esketamine Hydrochloride Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Esketamine Hydrochloride Injection Revenue Market Share by Type (2021-2026) Table 37. Global Esketamine Hydrochloride Injection Revenue Market Share by Type (2027-2032) Table 38. Global Esketamine Hydrochloride Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 40. Global Esketamine Hydrochloride Injection Sales by Type (2027-2032) & (K Units) Table 41. Global Esketamine Hydrochloride Injection Sales Market Share by Type (2021-2026) Table 42. Global Esketamine Hydrochloride Injection Sales Market Share by Type (2027-2032) Table 43. Global Esketamine Hydrochloride Injection Price by Type (2021-2026) & (US$/Unit) Table 44. Global Esketamine Hydrochloride Injection Price by Type (2027-2032) & (US$/Unit) Table 45. Global Esketamine Hydrochloride Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Esketamine Hydrochloride Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Esketamine Hydrochloride Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Esketamine Hydrochloride Injection Revenue Market Share by Application (2021-2026) Table 49. Global Esketamine Hydrochloride Injection Revenue Market Share by Application (2027-2032) Table 50. Global Esketamine Hydrochloride Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Esketamine Hydrochloride Injection Sales by Application (2027-2032) & (K Units) Table 53. Global Esketamine Hydrochloride Injection Sales Market Share by Application (2021-2026) Table 54. Global Esketamine Hydrochloride Injection Sales Market Share by Application (2027-2032) Table 55. Global Esketamine Hydrochloride Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Esketamine Hydrochloride Injection Price by Application (2027-2032) & (US$/Unit) Table 57. Jiangsu Hengrui Medicine Company Information Table 58. Jiangsu Hengrui Medicine Business Overview Table 59. Jiangsu Hengrui Medicine Esketamine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Jiangsu Hengrui Medicine Esketamine Hydrochloride Injection Product Portfolio Table 61. Jiangsu Hengrui Medicine Recent Development Table 62. Pfizer Company Information Table 63. Pfizer Business Overview Table 64. Pfizer Esketamine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Pfizer Esketamine Hydrochloride Injection Product Portfolio Table 66. Pfizer Recent Development Table 67. Laboratoires CDM Lavoisier Company Information Table 68. Laboratoires CDM Lavoisier Business Overview Table 69. Laboratoires CDM Lavoisier Esketamine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Laboratoires CDM Lavoisier Esketamine Hydrochloride Injection Product Portfolio Table 71. Laboratoires CDM Lavoisier Recent Development Table 72. North America Esketamine Hydrochloride Injection Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Esketamine Hydrochloride Injection Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 75. North America Esketamine Hydrochloride Injection Sales by Type (2027-2032) & (K Units) Table 76. North America Esketamine Hydrochloride Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 77. North America Esketamine Hydrochloride Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 78. North America Esketamine Hydrochloride Injection Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Esketamine Hydrochloride Injection Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 81. North America Esketamine Hydrochloride Injection Sales by Application (2027-2032) & (K Units) Table 82. North America Esketamine Hydrochloride Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 83. North America Esketamine Hydrochloride Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 84. North America Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America Esketamine Hydrochloride Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 88. North America Esketamine Hydrochloride Injection Sales by Country (2021-2026) & (K Units) Table 89. North America Esketamine Hydrochloride Injection Sales by Country (2027-2032) & (K Units) Table 90. North America Esketamine Hydrochloride Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 91. North America Esketamine Hydrochloride Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 92. United States Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 93. Canada Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 94. Mexico Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 95. Europe Esketamine Hydrochloride Injection Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Esketamine Hydrochloride Injection Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 98. Europe Esketamine Hydrochloride Injection Sales by Type (2027-2032) & (K Units) Table 99. Europe Esketamine Hydrochloride Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 100. Europe Esketamine Hydrochloride Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 101. Europe Esketamine Hydrochloride Injection Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Esketamine Hydrochloride Injection Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 104. Europe Esketamine Hydrochloride Injection Sales by Application (2027-2032) & (K Units) Table 105. Europe Esketamine Hydrochloride Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 106. Europe Esketamine Hydrochloride Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 107. Europe Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. Europe Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. Europe Esketamine Hydrochloride Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 111. Europe Esketamine Hydrochloride Injection Sales by Country (2021-2026) & (K Units) Table 112. Europe Esketamine Hydrochloride Injection Sales by Country (2027-2032) & (K Units) Table 113. Europe Esketamine Hydrochloride Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 114. Europe Esketamine Hydrochloride Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 115. Germany Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 116. France Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 117. U.K. Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 118. Italy Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 119. Russia Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 120. Spain Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 121. Netherlands Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 122. Switzerland Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 123. Sweden Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 124. Poland Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 125. China Esketamine Hydrochloride Injection Revenue by Type (2021-2026) & (US$ Million) Table 126. China Esketamine Hydrochloride Injection Revenue by Type (2027-2032) & (US$ Million) Table 127. China Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 128. China Esketamine Hydrochloride Injection Sales by Type (2027-2032) & (K Units) Table 129. China Esketamine Hydrochloride Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 130. China Esketamine Hydrochloride Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 131. China Esketamine Hydrochloride Injection Revenue by Application (2021-2026) & (US$ Million) Table 132. China Esketamine Hydrochloride Injection Revenue by Application (2027-2032) & (US$ Million) Table 133. China Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 134. China Esketamine Hydrochloride Injection Sales by Application (2027-2032) & (K Units) Table 135. China Esketamine Hydrochloride Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 136. China Esketamine Hydrochloride Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 137. Asia Esketamine Hydrochloride Injection Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Esketamine Hydrochloride Injection Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 140. Asia Esketamine Hydrochloride Injection Sales by Type (2027-2032) & (K Units) Table 141. Asia Esketamine Hydrochloride Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 142. Asia Esketamine Hydrochloride Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 143. Asia Esketamine Hydrochloride Injection Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Esketamine Hydrochloride Injection Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 146. Asia Esketamine Hydrochloride Injection Sales by Application (2027-2032) & (K Units) Table 147. Asia Esketamine Hydrochloride Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 148. Asia Esketamine Hydrochloride Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 149. Asia Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Asia Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Asia Esketamine Hydrochloride Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 153. Asia Esketamine Hydrochloride Injection Sales by Country (2021-2026) & (K Units) Table 154. Asia Esketamine Hydrochloride Injection Sales by Country (2027-2032) & (K Units) Table 155. Asia Esketamine Hydrochloride Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 156. Asia Esketamine Hydrochloride Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 157. Japan Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 158. South Korea Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 159. India Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 160. Australia Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 161. Taiwan Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 162. Southeast Asia Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 163. SAMEA Esketamine Hydrochloride Injection Revenue by Type (2021-2026) & (US$ Million) Table 164. SAMEA Esketamine Hydrochloride Injection Revenue by Type (2027-2032) & (US$ Million) Table 165. SAMEA Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 166. SAMEA Esketamine Hydrochloride Injection Sales by Type (2027-2032) & (K Units) Table 167. SAMEA Esketamine Hydrochloride Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 168. SAMEA Esketamine Hydrochloride Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 169. SAMEA Esketamine Hydrochloride Injection Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA Esketamine Hydrochloride Injection Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 172. SAMEA Esketamine Hydrochloride Injection Sales by Application (2027-2032) & (K Units) Table 173. SAMEA Esketamine Hydrochloride Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 174. SAMEA Esketamine Hydrochloride Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 175. SAMEA Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. SAMEA Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. SAMEA Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. SAMEA Esketamine Hydrochloride Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. SAMEA Esketamine Hydrochloride Injection Sales by Country (2021-2026) & (K Units) Table 180. SAMEA Esketamine Hydrochloride Injection Sales by Country (2027-2032) & (K Units) Table 181. SAMEA Esketamine Hydrochloride Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 182. SAMEA Esketamine Hydrochloride Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Brazil Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 184. Argentina Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 185. Chile Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 186. Colombia Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 187. Peru Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 188. Saudi Arabia Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 189. Israel Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 190. UAE Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 191. Turkey Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 192. Iran Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 193. Egypt Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Esketamine Hydrochloride Injection Distributors List Table 197. Esketamine Hydrochloride Injection Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Esketamine Hydrochloride Injection Image Figure 2. Global Esketamine Hydrochloride Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Esketamine Hydrochloride Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 2ml:50mg Image Figure 5. 5ml:25mg Image Figure 6. Others Image Figure 7. Global Esketamine Hydrochloride Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Esketamine Hydrochloride Injection Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals and Clinics Image Figure 10. Ambulatory Surgery Centers Image Figure 11. Global Esketamine Hydrochloride Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Esketamine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Esketamine Hydrochloride Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Esketamine Hydrochloride Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Esketamine Hydrochloride Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Esketamine Hydrochloride Injection Sales (2021-2032) & (K Units) Figure 17. Global Esketamine Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Esketamine Hydrochloride Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Esketamine Hydrochloride Injection Sales YoY (2021-2032) & (K Units) Figure 20. Europe Esketamine Hydrochloride Injection Sales YoY (2021-2032) & (K Units) Figure 21. China Esketamine Hydrochloride Injection Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Esketamine Hydrochloride Injection Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Esketamine Hydrochloride Injection Sales YoY (2021-2032) & (K Units) Figure 24. Global Esketamine Hydrochloride Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Esketamine Hydrochloride Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Esketamine Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Esketamine Hydrochloride Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Esketamine Hydrochloride Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Esketamine Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Esketamine Hydrochloride Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Esketamine Hydrochloride Injection Sales Market Share by Type (2021-2032) Figure 33. Global Esketamine Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Esketamine Hydrochloride Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Esketamine Hydrochloride Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Esketamine Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Esketamine Hydrochloride Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Esketamine Hydrochloride Injection Sales Market Share by Application (2021-2032) Figure 39. North America Esketamine Hydrochloride Injection Revenue Share by Type (2021-2032) Figure 40. North America Esketamine Hydrochloride Injection Sales Share by Type (2021-2032) Figure 41. North America Esketamine Hydrochloride Injection Revenue Share by Application (2021-2032) Figure 42. North America Esketamine Hydrochloride Injection Sales Share by Application (2021-2032) Figure 43. North America Esketamine Hydrochloride Injection Revenue Share by Country (2021-2032) Figure 44. North America Esketamine Hydrochloride Injection Sales Share by Country (2021-2032) Figure 45. Europe Esketamine Hydrochloride Injection Revenue Share by Type (2021-2032) Figure 46. Europe Esketamine Hydrochloride Injection Sales Share by Type (2021-2032) Figure 47. Europe Esketamine Hydrochloride Injection Revenue Share by Application (2021-2032) Figure 48. Europe Esketamine Hydrochloride Injection Sales Share by Application (2021-2032) Figure 49. Europe Esketamine Hydrochloride Injection Revenue Share by Country (2021-2032) Figure 50. Europe Esketamine Hydrochloride Injection Sales Share by Country (2021-2032) Figure 51. China Esketamine Hydrochloride Injection Revenue Share by Type (2021-2032) Figure 52. China Esketamine Hydrochloride Injection Sales Share by Type (2021-2032) Figure 53. China Esketamine Hydrochloride Injection Revenue Share by Application (2021-2032) Figure 54. China Esketamine Hydrochloride Injection Sales Share by Application (2021-2032) Figure 55. Asia Esketamine Hydrochloride Injection Revenue Share by Type (2021-2032) Figure 56. Asia Esketamine Hydrochloride Injection Sales Share by Type (2021-2032) Figure 57. Asia Esketamine Hydrochloride Injection Revenue Share by Application (2021-2032) Figure 58. Asia Esketamine Hydrochloride Injection Sales Share by Application (2021-2032) Figure 59. Asia Esketamine Hydrochloride Injection Revenue Share by Country (2021-2032) Figure 60. Asia Esketamine Hydrochloride Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Esketamine Hydrochloride Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Esketamine Hydrochloride Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Esketamine Hydrochloride Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Esketamine Hydrochloride Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Esketamine Hydrochloride Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Esketamine Hydrochloride Injection Sales Share by Country (2021-2032) Figure 67. Esketamine Hydrochloride Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Esketamine Hydrochloride Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 2ml:50mg
  • 5ml:25mg
  • Others
Applications
  • Hospitals and Clinics
  • Ambulatory Surgery Centers
Companies covered
  • Jiangsu Hengrui Medicine
  • Pfizer
  • Laboratoires CDM Lavoisier

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Esketamine Hydrochloride Injection Market by Type
  3. 1.2.1 Global Esketamine Hydrochloride Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 2ml:50mg
  5. 1.2.3 5ml:25mg
  6. 1.2.4 Others
  7. 1.3 Esketamine Hydrochloride Injection Market by Application
  8. 1.3.1 Global Esketamine Hydrochloride Injection Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals and Clinics
  10. 1.3.3 Ambulatory Surgery Centers
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Esketamine Hydrochloride Injection Market Dynamics
  1. 2.1 Esketamine Hydrochloride Injection Industry Trends
  2. 2.2 Esketamine Hydrochloride Injection Industry Drivers
  3. 2.3 Esketamine Hydrochloride Injection Industry Opportunities and Challenges
  4. 2.4 Esketamine Hydrochloride Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Esketamine Hydrochloride Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Esketamine Hydrochloride Injection Revenue by Region
  3. 3.2.1 Global Esketamine Hydrochloride Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Esketamine Hydrochloride Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Esketamine Hydrochloride Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Esketamine Hydrochloride Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Esketamine Hydrochloride Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Esketamine Hydrochloride Injection Sales by Region
  9. 3.4.1 Global Esketamine Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Esketamine Hydrochloride Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Esketamine Hydrochloride Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Esketamine Hydrochloride Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Esketamine Hydrochloride Injection Revenue by Manufacturers
  2. 4.1.1 Global Esketamine Hydrochloride Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Esketamine Hydrochloride Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Esketamine Hydrochloride Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Esketamine Hydrochloride Injection Sales by Manufacturers
  6. 4.2.1 Global Esketamine Hydrochloride Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Esketamine Hydrochloride Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Esketamine Hydrochloride Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Esketamine Hydrochloride Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Esketamine Hydrochloride Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Esketamine Hydrochloride Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Esketamine Hydrochloride Injection Manufacturers, Product Type & Application
  13. 4.7 Global Esketamine Hydrochloride Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Esketamine Hydrochloride Injection Market CR5 and HHI
  16. 4.8.2 2025 Esketamine Hydrochloride Injection Tier 1, Tier 2, and Tier 3
5 Esketamine Hydrochloride Injection Market by Type
  1. 5.1 Global Esketamine Hydrochloride Injection Revenue by Type
  2. 5.1.1 Global Esketamine Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Esketamine Hydrochloride Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Esketamine Hydrochloride Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Esketamine Hydrochloride Injection Sales by Type
  6. 5.2.1 Global Esketamine Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Esketamine Hydrochloride Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Esketamine Hydrochloride Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Esketamine Hydrochloride Injection Price by Type
6 Esketamine Hydrochloride Injection Market by Application
  1. 6.1 Global Esketamine Hydrochloride Injection Revenue by Application
  2. 6.1.1 Global Esketamine Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Esketamine Hydrochloride Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Esketamine Hydrochloride Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Esketamine Hydrochloride Injection Sales by Application
  6. 6.2.1 Global Esketamine Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Esketamine Hydrochloride Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Esketamine Hydrochloride Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Esketamine Hydrochloride Injection Price by Application
7 Company Profiles
  1. 7.1 Jiangsu Hengrui Medicine
  2. 7.1.1 Jiangsu Hengrui Medicine Company Information
  3. 7.1.2 Jiangsu Hengrui Medicine Business Overview
  4. 7.1.3 Jiangsu Hengrui Medicine Esketamine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Jiangsu Hengrui Medicine Esketamine Hydrochloride Injection Product Portfolio
  6. 7.1.5 Jiangsu Hengrui Medicine Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Esketamine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Esketamine Hydrochloride Injection Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 Laboratoires CDM Lavoisier
  14. 7.3.1 Laboratoires CDM Lavoisier Company Information
  15. 7.3.2 Laboratoires CDM Lavoisier Business Overview
  16. 7.3.3 Laboratoires CDM Lavoisier Esketamine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Laboratoires CDM Lavoisier Esketamine Hydrochloride Injection Product Portfolio
  18. 7.3.5 Laboratoires CDM Lavoisier Recent Developments
8 North America
  1. 8.1 North America Esketamine Hydrochloride Injection Market Size by Type
  2. 8.1.1 North America Esketamine Hydrochloride Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Esketamine Hydrochloride Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Esketamine Hydrochloride Injection Price by Type (2021-2032)
  5. 8.2 North America Esketamine Hydrochloride Injection Market Size by Application
  6. 8.2.1 North America Esketamine Hydrochloride Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Esketamine Hydrochloride Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Esketamine Hydrochloride Injection Price by Application (2021-2032)
  9. 8.3 North America Esketamine Hydrochloride Injection Market Size by Country
  10. 8.3.1 North America Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Esketamine Hydrochloride Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Esketamine Hydrochloride Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Esketamine Hydrochloride Injection Market Size by Type
  2. 9.1.1 Europe Esketamine Hydrochloride Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Esketamine Hydrochloride Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Esketamine Hydrochloride Injection Price by Type (2021-2032)
  5. 9.2 Europe Esketamine Hydrochloride Injection Market Size by Application
  6. 9.2.1 Europe Esketamine Hydrochloride Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Esketamine Hydrochloride Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Esketamine Hydrochloride Injection Price by Application (2021-2032)
  9. 9.3 Europe Esketamine Hydrochloride Injection Market Size by Country
  10. 9.3.1 Europe Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Esketamine Hydrochloride Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Esketamine Hydrochloride Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Esketamine Hydrochloride Injection Market Size by Type
  2. 10.1.1 China Esketamine Hydrochloride Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Esketamine Hydrochloride Injection Sales by Type (2021-2032)
  4. 10.1.3 China Esketamine Hydrochloride Injection Price by Type (2021-2032)
  5. 10.2 China Esketamine Hydrochloride Injection Market Size by Application
  6. 10.2.1 China Esketamine Hydrochloride Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Esketamine Hydrochloride Injection Sales by Application (2021-2032)
  8. 10.2.3 China Esketamine Hydrochloride Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Esketamine Hydrochloride Injection Market Size by Type
  2. 11.1.1 Asia Esketamine Hydrochloride Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Esketamine Hydrochloride Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Esketamine Hydrochloride Injection Price by Type (2021-2032)
  5. 11.2 Asia Esketamine Hydrochloride Injection Market Size by Application
  6. 11.2.1 Asia Esketamine Hydrochloride Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Esketamine Hydrochloride Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Esketamine Hydrochloride Injection Price by Application (2021-2032)
  9. 11.3 Asia Esketamine Hydrochloride Injection Market Size by Country
  10. 11.3.1 Asia Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Esketamine Hydrochloride Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Esketamine Hydrochloride Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Esketamine Hydrochloride Injection Market Size by Type
  2. 12.1.1 SAMEA Esketamine Hydrochloride Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Esketamine Hydrochloride Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Esketamine Hydrochloride Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Esketamine Hydrochloride Injection Market Size by Application
  6. 12.2.1 SAMEA Esketamine Hydrochloride Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Esketamine Hydrochloride Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Esketamine Hydrochloride Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Esketamine Hydrochloride Injection Market Size by Country
  10. 12.3.1 SAMEA Esketamine Hydrochloride Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Esketamine Hydrochloride Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Esketamine Hydrochloride Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Esketamine Hydrochloride Injection Value Chain Analysis
  2. 13.1.1 Esketamine Hydrochloride Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Esketamine Hydrochloride Injection Production Mode & Process
  6. 13.2 Esketamine Hydrochloride Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Esketamine Hydrochloride Injection Distributors
  9. 13.2.3 Esketamine Hydrochloride Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research